1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

被引：0
|
作者：
Markus Mayrhofer
Hanna Göransson Kultima
Helgi Birgisson
Magnus Sundström
Lucy Mathot
Karolina Edlund
Björn Viklund
Tobias Sjöblom
Johan Botling
Patrick Micke
Lars Påhlman
Bengt Glimelius
Anders Isaksson
机构：
[1] Uppsala University,Science for Life Laboratory, Department of Medical Sciences
[2] Uppsala University,Department of Surgical Sciences
[3] Uppsala University,Science for Life Laboratory, Department of Immunology Genetics and Pathology
[4] Uppsala University,Department of Radiology, Oncology and Radiation Science
[5] Leibniz Research Centre for Working Environment and Human Factors,undefined
来源：
BMC Cancer | / 14卷
关键词：
Colon cancer; Prognostic marker; Allele-specific copy number analysis; Genome duplication; 1p36; Metastasis; Tumour dissemination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
    Mayrhofer, Markus
    Kultima, Hanna Goransson
    Birgisson, Helgi
    Sundstrom, Magnus
    Mathot, Lucy
    Edlund, Karolina
    Viklund, Bjorn
    Sjoblom, Tobias
    Botling, Johan
    Micke, Patrick
    Pahlman, Lars
    Glimelius, Bengt
    Isaksson, Anders
    BMC CANCER, 2014, 14
  • [2] Stage II-III colon cancer: a comparison of survival calculators
    Lemini, Riccardo
    Attwood, Kristopher
    Pecenka, Stacey
    Grego, Juliet
    Spaulding, Aaron C.
    Nurkin, Steven
    Colibaseanu, Dorin T.
    Gabriel, Emmanuel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 1091 - 1098
  • [3] Further clinical delineation and microsatellite profile in 1p36 deletion patients.
    Vargas, FR
    Llerena , JC
    Ramos, MC
    Barbosa-Neto, JG
    Souza, KRL
    Ramos, H
    Santos, RR
    de Almeida, JCC
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 271 - 271
  • [4] Prognostic relevance of Src activation in stage II-III colon cancer
    Martinez-Perez, Julia
    Lopez-Calderero, Iker
    Saez, Carmen
    Benavent, Marta
    Limon, Maria L.
    Gonzalez-Exposito, Reyes
    Soldevilla, Beatriz
    Carmen Riesco-Martinez, Maria
    Salamanca, Javier
    Carnero, Amancio
    Garcia-Carbonero, Rocio
    HUMAN PATHOLOGY, 2017, 67 : 119 - 125
  • [5] Glycemic Variability Within 1 Year Following Surgery for Stage II-III Colon Cancer
    Mandolfo, Natalie Rasmussen
    Berger, Ann M.
    Struwe, Leeza
    Hanna, Kathleen M.
    Goldner, Whitney
    Klute, Kelsey
    Langenfeld, Sean
    Hammer, Marilyn
    BIOLOGICAL RESEARCH FOR NURSING, 2022, 24 (01) : 64 - 74
  • [6] Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
    Penney, Kathryn L.
    Banbury, Barbara L.
    Bien, Stephanie
    Harrison, Tabitha A.
    Hua, Xinwei
    Phipps, Amanda I.
    Sun, Wei
    Song, Mingyang
    Joshi, Amit D.
    Alberts, Steven R.
    Allegra, Carmen J.
    Atkins, James
    Colangelo, Linda H.
    George, Thomas J.
    Goldberg, Richard M.
    Lucas, Peter C.
    Nair, Suresh G.
    Shi, Qian
    Sinicrope, Frank A.
    Wolmark, Norman
    Yothers, Greg
    Peters, Ulrike
    Newcomb, Polly A.
    Chan, Andrew T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (12) : 2717 - +
  • [7] PROGNOSTIC FACTORS FOR PATIENTS WITH RECURRENT DISEASE IN STAGE II-III COLON CANCER
    Mateo, Joaquin
    Lopez-Doriga, Adriana
    Navarro, Matilde
    Martinez Villacampa, M. Mercedes
    Laquente, Berta
    Soler, Gemma
    Ramos, Emilio
    Biondo, Sebastiano
    Macia, Ivan
    Salazar, Ramon
    Santos, Cristina
    ANNALS OF ONCOLOGY, 2011, 22 : v107 - v107
  • [8] Novel Model to Predict the Prognosis of Patients with Stage II-III Colon Cancer
    Xu, Yansong
    Liang, Fangfang
    Chen, Yi
    Wang, Zhen
    Zhong, Huage
    Tang, Weizhong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [9] Association of PTEN loss and local recurrence in stage II-III colon cancer
    Jiang, Z.
    Mehta, T. R.
    You, Y. N.
    Chang, G. J.
    Eng, C.
    Overman, M. J.
    Maru, D.
    Hamilton, S. R.
    Kopetz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [10] Wnt5a expression and prognosis in stage II-III colon cancer
    Lund, Cecilia Margareta
    Dyhl-Polk, Anne
    Nielsen, Dorte Lisbeth
    Riis, Lene Buhl
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
12345